Literature DB >> 316285

Chronic mucocutaneous candidiasis. Immunologic studies of three generations of a single family.

W M Sams, J L Jorizzo, R Snyderman, B V Jegasothy, F E Ward, M Weiner, J G Wilson, W J Yount, S B Dillard.   

Abstract

A family consisting of eight members in three generations (age 10 months to 53 years) affected with chronic mucocutaneous candidiasis was studied along with three unaffected relatives. Dermatophytosis, loss of teeth and recurrent viral infections were present in some members. Results of tests for endocrinologic, muscle or liver disease, thymoma, iron deficiency, antitissue antibodies and malabsorption were normal in all patients. Antibody function and levels, B cell counts, serum complement, leukocyte enzymes, chemotaxis, phagocytosis and adherence were normal in all members. Plasma inhibitors to lymphocyte transformation and leukocyte inhibitory factor were not found. No unique HLA haplotype or antigen segregated in this family. Evaluation of cell-mediated immunity revealed total cutaneous anergy in three of eight whereas four of the other five had negative lymphocyte transformation and skin tests to Candida but responded normally to other antigens. Leukocyte inhibitory factor was not produced to Candida antigen in all four patients tested. T cell counts were within normal limits in all. Extensive evaluation of all limbs of the immune system in this family revealed a defect in cell-mediated immunity to Candida that appeared to be inherited as a dominant characteristic.

Entities:  

Mesh:

Substances:

Year:  1979        PMID: 316285     DOI: 10.1016/0002-9343(79)90635-1

Source DB:  PubMed          Journal:  Am J Med        ISSN: 0002-9343            Impact factor:   4.965


  10 in total

Review 1.  Fungal skin infections.

Authors:  R J Hay
Journal:  Arch Dis Child       Date:  1992-09       Impact factor: 3.791

2.  Primary immunodeficiency diseases in Norway.

Authors:  A Stray-Pedersen; T G Abrahamsen; S S Frøland
Journal:  J Clin Immunol       Date:  2000-11       Impact factor: 8.317

Review 3.  Inborn errors of human IL-17 immunity underlie chronic mucocutaneous candidiasis.

Authors:  Anne Puel; Sophie Cypowyj; László Maródi; Laurent Abel; Capucine Picard; Jean-Laurent Casanova
Journal:  Curr Opin Allergy Clin Immunol       Date:  2012-12

Review 4.  Chronic mucocutaneous candidiasis.

Authors:  C H Kirkpatrick
Journal:  Eur J Clin Microbiol Infect Dis       Date:  1989-05       Impact factor: 3.267

5.  An immune defect causing dominant chronic mucocutaneous candidiasis and thyroid disease maps to chromosome 2p in a single family.

Authors:  T P Atkinson; A A Schäffer; B Grimbacher; H W Schroeder; C Woellner; C S Zerbe; J M Puck
Journal:  Am J Hum Genet       Date:  2001-08-21       Impact factor: 11.025

6.  Evaluation of auto-antibodies in chronic mucocutaneous candidiasis without endocrinopathy.

Authors:  M Zouali; E Drouhet; A Eyquem
Journal:  Mycopathologia       Date:  1984-02-15       Impact factor: 2.574

7.  A homozygous CARD9 mutation in a family with susceptibility to fungal infections.

Authors:  Erik-Oliver Glocker; Andre Hennigs; Mohammad Nabavi; Alejandro A Schäffer; Cristina Woellner; Ulrich Salzer; Dietmar Pfeifer; Hendrik Veelken; Klaus Warnatz; Fariba Tahami; Sarah Jamal; Annabelle Manguiat; Nima Rezaei; Ali Akbar Amirzargar; Alessandro Plebani; Nicole Hannesschläger; Olaf Gross; Jürgen Ruland; Bodo Grimbacher
Journal:  N Engl J Med       Date:  2009-10-29       Impact factor: 91.245

Review 8.  Invasive oesophageal candidiasis: current and developing treatment options.

Authors:  Jose A Vazquez
Journal:  Drugs       Date:  2003       Impact factor: 9.546

9.  Genetic susceptibility to dermatophytosis.

Authors:  R J Hay
Journal:  Eur J Epidemiol       Date:  1992-05       Impact factor: 8.082

10.  Chronic mucocutaneous candidiasis and primary hypothyroidism in two families.

Authors:  Anne Grethe Myhre; Asbjørg Stray-Pedersen; Steinar Spangen; Eigill Eide; Dag Veimo; Per Morten Knappskog; Tore G Abrahamsen; Eystein S Husebye
Journal:  Eur J Pediatr       Date:  2004-10       Impact factor: 3.183

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.